GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhangzhou Pientzehuang Pharmaceutical Co Ltd (SHSE:600436) » Definitions » Change In Payables And Accrued Expense

Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436) Change In Payables And Accrued Expense : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Zhangzhou Pientzehuang Pharmaceutical Co Change In Payables And Accrued Expense?

Zhangzhou Pientzehuang Pharmaceutical Co's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Zhangzhou Pientzehuang Pharmaceutical Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Mar. 2024 .

Zhangzhou Pientzehuang Pharmaceutical Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was ¥0 Mil. It means Zhangzhou Pientzehuang Pharmaceutical Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .


Zhangzhou Pientzehuang Pharmaceutical Co Change In Payables And Accrued Expense Historical Data

The historical data trend for Zhangzhou Pientzehuang Pharmaceutical Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhangzhou Pientzehuang Pharmaceutical Co Change In Payables And Accrued Expense Chart

Zhangzhou Pientzehuang Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Payables And Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Zhangzhou Pientzehuang Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Zhangzhou Pientzehuang Pharmaceutical Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhangzhou Pientzehuang Pharmaceutical Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Zhangzhou Pientzehuang Pharmaceutical Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436) Business Description

Traded in Other Exchanges
N/A
Address
No.1 Shangjie, Xiangcheng, Fujian, Zhangzhou, CHN, 363000
Zhangzhou Pientzehuang Pharmaceutical Co Ltd produces and sells Chinese medicines. The company's product categories include drugs and healthcare products, healthy foods, cosmetics, daily chemicals, and medical instruments. Some of its products include Xinshubao Tablet, Yindan Pinggan Capsule, Liuwei Dihuang Pills, and Chuangbei Qingfei Syrup.

Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436) Headlines

No Headlines